M. Ried

Real-Time Single-Molecule Imaging of the Infection Pathway of an Adeno-Associated Virus

M. Hallek, C. Bräuchle, G. Seisenberger, 2001, Science.

Receptor targeting of adeno-associated virus vectors

M. Hallek, L. Perabò, H. Büning, 2003, Gene Therapy.

Single virus tracing: visualization of the infection pathway of a virus into a living cell.

M. Hallek, C. Bräuchle, H. Büning, 2002, Chemphyschem : a European journal of chemical physics and physical chemistry.

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display.

M. Hallek, L. Perabò, D. Kofler, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Erratum: Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2 (Nature Medicine (1999) 5 (1052-1056))

G. Deléage, M. Hallek, K. Leike, 1999 .

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2

G. Deléage, M. Hallek, K. Leike, 1999, Nature Medicine.

The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.

M. Hallek, K. Leike, J. Kleinschmidt, 2002, The Journal of general virology.

Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody-Mediated Vector Retargeting to Specific Cell Surface Receptors

M. Hallek, K. Leike, H. Büning, 2002, Journal of Virology.

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2

G. Deléage, M. Hallek, K. Leike, 1999, Nature Medicine.

Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody-Mediated Vector Retargeting to Specific Cell Surface Receptors

M. Hallek, K. Leike, H. Büning, 2002 .